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Abstract
Background: Previous reports show a high proportion of young CRC patients in Iran. In this study
we aim to look for the clustering of colorectal cancer in families of a series of CRC patients from
Iran.
Methods: The family history of cancer is traced in 449 CRC patients of which 112 were 45 yrs or
younger and 337 were older than 45 yrs at time of diagnosis. The patients were admitted in two
hospitals in Tehran, during a 4-year period.
Results: Clinical diagnosis of HNPCC was established in 21 (4.7%) probands. Family history of
CRC was more frequently reported by early-onset than by late-onset patients (29.5% vs. 12.8%, p
< 0.001).
Distribution of tumor site differed significantly between those with and without family history of
CRC. Right colon cancer was the most frequent site (23/45, 35.4%) observed in patients with
positive family history of colorectal cancer.
Conclusion: The relatively high frequency of CRC clustering along with HNPCC in our patients
should be further confirmed with larger sample size population-based and genetic studies to
establish a cost effective molecular screening for the future.
Background
Colorectal carcinoma (CRC) is the third most common
cause of cancer related deaths in the world [1] with some
well known hereditary forms. Hereditary non-polyposis
colorectal cancer (HNPCC) is the most common type of
hereditary CRC. The frequency of HNPCC varies world-
wide ranging from 1 to 6% [2]. This variability could be
due to discrepancies in definitions (clinical vs. molecular
criteria) and also regional heterogeneity [3-5].
Apart from defined genetic syndromes of CRC, both retro-
spective and prospective studies proved that familial his-
tory of colorectal cancer could increase a person's lifetime
risk of colorectal cancer significantly [6,7].
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CRC with age-adjusted rate of 6–7.9 per 100,000 person
per year is the fourth most common cancer in Iran [8,9].
Early-onset colorectal cancer (less than 40 yrs of age at
time of diagnosis) comprises almost one fifth of all CRC
cases in the country [9,10]. This proportion is considera-
bly lower in high-risk countries, with rates ranging from
2% to 8% [11,12]. The high proportions of young CRC
cases seen in Iran, and probably many neighboring coun-
tries, are mainly due to the young age-structure of these
countries and relatively low rates of CRC in older individ-
uals [10].
Up to now there have been no reports addressing the
familial aggregation of colorectal cancer in Iran. In the
current study, we aimed to study the clustering of colorec-
tal cancer in families of CRC patients and make a compar-
ison of frequency of colorectal and other types of cancer
in family members of early-onset with that of late-onset
CRC patients.
Methods
We reviewed all patients' documents with a pathologically
confirmed diagnosis of colorectal adenocarcinoma admit-
ted in two hospitals in Tehran between January 2000 and
February 2004. Patients with familial adenomatous poly-
posis or those with underlying inflammatory bowel dis-
ease were excluded. Of 662 patients registered in the
database, 174 patients were lost due to change of address
or contact phone number, 33 refused to be interviewed
and 6 were excluded because of incomplete family history
accordingly, 449 CRC cases (112 younger than 45 yrs and
337 older than 45 yrs at diagnosis) or their close family
members participated in this study.
Demographic, clinical and tumor-related characteristics of
patients were recorded based on their hospital docu-
ments. These parameters included gender, age at diagno-
sis, place and date of birth and tumor-related factors such
as location, stage, degree of differentiation and mucus
production.
All of these patients or their siblings/parents (in the case
the patient was dead or not available) were interviewed to
trace their family history of cancer including occurrence of
malignancy in the family, type of cancer and the age at
diagnosis of the affected family member. Pedigrees were
drawn at least up to second-degree relatives. The obtained
pedigrees were reconfirmed by interviewing another
member of family. In addition, we tried to verify reported
malignancies in relatives by asking for their medical
records, if available. In Iran, family relations are very
strong and people are usually aware of serious diseases
such as cancer in their relatives.
Patients belonging to families fulfilling the AmsterdamII
criteria, including at least three members with an HNPCC-
associated cancer (colorectal, endometrial, small bowel,
ureter, renal pelvis) in at least two successive generations,
one being a first-degree relative of the other two and at
least one diagnosed before the age of 50 years, were clas-
sified as HNPCC [13].
Patients from families which did not fulfill Amsterdam
criteria but with at least two relatives with colorectal can-
cer in a first- or second-degree relationship were classified
as Hereditary Colorectal Cancer (HCRC).
This study was approved by the Digestive Disease
Research Center of Tehran University of Medical Sciences
Institutional Review Board and informed consents were
obtained from patients or their families participating in
the study.
Statistical analysis
Qualitative variables were compared by chi-squared test
with Yates correction when needed. A P value of less than
0.05 was considered to indicate a statistically significant
difference. All calculations were performed using the 11.5
SPSS software package (SPSS Inc., Chicago, IL, USA).
Results
Four-hundred forty nine (449) CRC patients with patho-
logically confirmed colorectal adenocarcinoma were
enrolled in the study.
Tumor sites of early-onset and late-onset group are sepa-
rately shown in table 1. No significant difference in local-
ization of tumor was observed between the two groups.
Family history of cancer up to second-degree relatives
were observed in 60 (53.5%) of early-onset and 144
(43.5%) of late-onset patients respectively. The most com-
mon cancers affecting first and second degree relatives are
shown in table 2. History of colorectal cancer in at least
one relative was significantly more frequent in early-onset
patients; 33 (29.5%) comparing to 43 (12.8%) cases in
late-onset group. Frequency of other types of cancers
reported in the family did not differ significantly between
the two age groups.
The frequency of hereditary types of colorectal cancer in
two age groups is shown in Table 3. Among 21 HNPCC
families, nineteen fulfilled the Amsterdam criteria I hav-
ing at least three members with CRC in two consecutive
generations, one being a first-degree relative of the other
two and at least one diagnosed before the age of 50 years
[14]. The other 2 families fulfilled the Amsterdam criteria
II with history of colorectal and endometrial cancer in the
family.BMC Cancer 2005, 5:112 http://www.biomedcentral.com/1471-2407/5/112
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Distribution of tumor site differed significantly between
patients with family history of CRC and those without this
history (Table 4,†); In total, right colon cancer was seen
more frequently than other locations in probands with
family history of CRC, in contrast to higher percentage of
left colon carcinoma in patients without this history.
Rectal carcinoma was rarely seen in young patients with
positive family history; 12.1% comparing to 38% in those
without family history (p = 0.025) or cases belonging to
the other age group.
Discussion
This report represents the first study to characterize the
profile of familial CRC aggregation in Iranian patients.
Although we tried to include all recorded patients in this
study, familial profile of 213 (32%) cases could not be
determined and analyzed here (see method). However,
there were no significant differences in age, sex and tumor
localization of participating and non participating
patients.
The estimation of the frequency of HNPCC among CRC
patients based on family history varies in different
Table 1: CRC characteristics among young and old patients.
Variable Early-onset (n = 112) Late-onset (n = 337) P Value†
Sex (M/F) 43/69 138/199 NS††
Tumor Location
Right 30(26.8%) 62(18.4%) NS
Left 43(38.4%) 134(39.8%) NS
Rectum 36(32.1%) 141(41.8%) NS
NOS 3(2.6%) 0 ___
†Assigns the significance of the differences between two group
†† NS: Not significant
Table 2: Frequent cancer sites in relatives of early and late-onset CRC patients.
Early-onset (n = 112) Late-onset (n = 337) P Value†
Family History (FHx) of cancer 60(53.6%) 144(42.7%) NS††
FHx of CRC 33(29.4%) 43(12.8%) <0.001
Breast 11(9.8%) 17(5%) NS
Stomach 9(8%) 17(5%) NS
Lung 5(4.5%) 25(7.5%) NS
Leukemia & Lymphoma 4(3.6%) 14(4.2%) NS
Brain 4(3.6%) 9(2.7%) NS
Endometrial 2(1.8%) 12(3.6%) NS
†Assigns the significance of the differences between two group
†† NS: Not significant
Table 3: Hereditary forms of CRC in two age groups.
Variable Total
(n = 449)
Early-onset
(n = 112)
Late-onset
(n = 337)
P Value†
HNPCC 21(4.7%) 12(10.7%) 9(2.9%) <0.001
HCRC 15(3.4%) 9(8%) 6(1.7%) <0.001
One first-degree relative 
with CRC
26(5.8%) 7(6%) 19(5.6%) NS††
†Assigns the significance of the differences between two group
†† NS: Not significantBMC Cancer 2005, 5:112 http://www.biomedcentral.com/1471-2407/5/112
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populations. In a multicenter study on Finnish popula-
tion, the frequency of families meeting the Amsterdam
criteria was 1.7% [15]. Ponz et al estimated the frequency
of HNPCC among CRC cases to be 3.4–4.5% in Northern
Italy [3], while in Spanish population; clinical diagnosis
of HNPCC was established in 2.5% of CRC patients [16].
In a pilot study by Soliman a et al, 7.2% of Egyptian color-
ectal patients had family history suggestive of hereditary
non polyposis colorectal cancer [17]. Discrepancies in the
reported frequency of HNPCC between populations prob-
ably reflect population differences. Frequency of this syn-
drome in Iran has not yet been studied. In our study, a
total of 21 cases (4.7%) met the Amsterdam criteria II.
This relatively high frequency of HNPCC in our patients
should be further confirmed with larger sample size, pop-
ulation-based, and genetic studies.
HNPCC clinical diagnosis was significantly more preva-
lent among younger patients in agreement with previous
studies [18,19]. In some other studies, the mean age at
diagnosis for HNPCC patients was reported to be between
52–60 yrs [20,21]. However, we found that almost 3% of
patients over 45 yrs belonged to families fulfilling Amster-
dam criteria. This indicates that taking detailed family his-
tory even in old cases is necessary and could identify CRC
families with known genetic risk.
Also, we have found higher frequency of familial cluster-
ing of CRC apart from HNPCC cases in younger patients
(Table 3).This in agreement with studies in other popula-
tions, suggests stronger genetic background in younger
onset CRC patients [22].
We observed 15 families who did not fulfill HNPCC crite-
ria, but with more than 2 CRC relatives in the family
(Table 3). It was previously suggested that some familial
cancers might be due to common environmental expo-
sures of family members rather than genetic clustering of
cancer [23], but more recently; it has been shown that
familial risk for CRC are mainly due to heritable causes
[24]. Therefore, these families could be added to HNPCC
families to undergo analysis of MMR genes [25]. How-
ever, not all CRC clustering could be attributed to defects
in genes involved in mismatch repair [26], and unknown
loci may be responsible for much of the familial aggrega-
tion of CRC [27].
It is suggested that family history of CRC is related to the
localization of tumor. Some studies proposed a stronger
familial component for proximal than for distal colon
cancer [6,28], while this association was not observed in
other studies [29]. In our study, right-sided tumors
occurred more frequently in patients with positive family
history of CRC compared to those without this history
(36.9% vs. 17.7%, p < 0.001). This pattern was almost the
same in patients over and under 45 yrs of age (Table 4).
Also, we have found rectal cancer to be less frequent
among younger probands with positive CRC family his-
tory. This is in agrremnet with the previous report of Ols-
son L and Lindblom A, in which the frequency of sigmoid
cancer was shown to be lower among familial CRC cases
compared to sporadic patients [21]. Altogether, these
findings could indicate a difference in carcinogenic path-
ways based on the tumor location with heritable causes
mostly affecting the right colon and exogenous factors
Table 4: distribution of tumor sites by family history of colorectal cancer according to age of the proband.
Age group Positive FH† of CRC Negative FH of CRC
CRC localization
Total† N = 76 N = 373
Righta 28(36.9%) 66(17.7%)
Left 24(31.6%) 167(44.8%)
Rectum 22(29%) 139(37.3%)
NOS 2(2.5%) 1(0.03%)
Over 45 N = 43 N = 294
Rightb 14(32.6%) 49(16.7%)
Left 11(25.6%) 136(46.3%)
Rectum 18(41.8%) 109(37.1%)
Less than 45 N = 33 N = 79
Rightc 14(42.4%) 17(21.5%)
Left 13(39.4%) 31(39.2%)
Rectum 4(12.1%) 30(38%)
NOS 2(6.1%) 1(1.3%)
†: difference of tumor site distribution between two groups (p < 0.001)
a,b,c: p < 0.05BMC Cancer 2005, 5:112 http://www.biomedcentral.com/1471-2407/5/112
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responsible for carcinogenesis in the distal part of the
large bowel. It has been suggested that chromosomal
instability affecting allelic losses of APC and P53 are more
frequent in distal colonic and rectal tumors than in prox-
imal lesions. On the other hand, microsatellite instability
is more common in proximal tumors [30].
Appropriate screening strategies should be considered to
decrease the burden of CRC in Iran.Our ongoing molecu-
lar and genetic studies including analysis of micro satellite
instability and mismatch repair gene mutations would
most likely help us to characterize the molecular basis for
the observed clustering of colorectal cancer among fami-
lies of younger onset patients and could lead to the adop-
tion of simpler and more cost effective molecular
screening in the future.
Conclusion
Clinical diagnosis of HNPCC was observed in 21 (4.7%)
probands in our study. Familial clustering of CRC was
more frequent in younger probands. The right side of the
colon was more frequently affected in patients with posi-
tive family history of CRC. This indicates that a detailed
family history is mandatory in colorectal cancer patients
with particular attention to younger onset cases and those
with right-sided tumors.
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